Holen Sie sich die Stockscreener-App
359.22
1.20%
4.63
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$354.59
Offen:
$359.29
24-Stunden-Volumen:
10,706
Relative Volume:
0.02
Marktkapitalisierung:
$21.35B
Einnahmen:
$2.91B
Nettoeinkommen (Verlust:
$622.64M
KGV:
34.28
EPS:
10.48
Netto-Cashflow:
$620.14M
1W Leistung:
+2.98%
1M Leistung:
+5.28%
6M Leistung:
-6.73%
1J Leistung:
+9.52%
1-Tages-Spanne:
$355.31
$359.79
1-Wochen-Bereich:
$340.33
$360.88
52-Wochen-Spanne:
$279.24
$423.56
Waters Corp Stock (WAT) Company Profile
Firmenname
Waters Corp
Sektor
Branche
Telefon
(508) 478-2000
Adresse
34 MAPLE ST, MILFORD, MA
Vergleichen Sie WAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
358.81 | 20.67B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
406.41 | 150.35B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
191.75 | 133.69B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
517.38 | 40.28B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.22 | 31.05B | 6.53B | 1.26B | 1.31B | 4.35 |
|
MTD
Mettler Toledo International Inc
|
1,171.94 | 23.55B | 3.87B | 863.14M | 864.45M | 40.53 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2023-11-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-05-18 | Eingeleitet | Barclays | Overweight |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Hochstufung | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Herabstufung | Needham | Hold → Underperform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Sell |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-01-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Eingeleitet | Needham | Hold |
| 2018-12-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-11 | Hochstufung | Cleveland Research | Sell → Neutral |
Alle ansehen
Waters Corp Aktie (WAT) Neueste Nachrichten
Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality - marketscreener.com
Waters Corporation’s SWOT analysis: stock outlook amid biotech boom - Investing.com
Waters Corp (WAT) Stock Price Up 3.88% on May 27 - GuruFocus
Waters acquires Halo Labs, expanding biological analysis portfolio - SelectScience
Waters Corporation (WAT) Announces Results of Annual Stockholders Meeting - GuruFocus
Waters Corp. acquires specialized imaging firm Halo Labs - Worcester Business Journal
Petri Dish: Thermo Fisher’s new partner; Waters buys California company - The Business Journals
Waters Corporation acquired Optofluidics, Inc. - marketscreener.com
Waters Acquires Halo Labs, Expands Biologic Analysis Portfolio - Contract Pharma
Waters Acquires Halo Labs - marketscreener.com
Waters (WAT) Enhances Capabilities with Acquisition of Halo Labs | WAT Stock News - GuruFocus
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio - PR Newswire
Waters Co. (NYSE:WAT) Stock Position Raised by Cetera Investment Advisers - Defense World
Waters (WAT) Sees Price Target Increase Amid Market Caution | WAT Stock News - GuruFocus
Ameriprise Financial Inc. Trims Stake in Waters Co. (NYSE:WAT) - Defense World
Waters Co. (NYSE:WAT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Waters Corp's India business boosted by rush for weight-loss drugs - MSN
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters CEO Brings Analytical Instruments Innovation to Jefferies Healthcare Conference 2025 - Stock Titan
HSBC lifts Carnival Corp. rating as it is now ‘in calmer waters’ - Investing.com Australia
Waters Sees Surge in India Demand as Drugmakers Race to Develop Weight-Loss Drug Generics - marketscreener.com
Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance - 巴士的報
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
What Makes Waters Corporation (WAT) a Lucrative Investment? - Yahoo Finance
Waters (NYSE:WAT) Stock Unloaded Rep. Robert Bresnahan, Jr. - Defense World
Leerink Partnrs Has Negative Forecast for Waters Q3 Earnings - Defense World
Q2 Earnings Estimate for Waters Issued By Leerink Partnrs - Defense World
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT St - GuruFocus
Analyst Expectations For Waters's Future - Benzinga
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT Stock News - GuruFocus
UBS Lowers Price Target for Waters (WAT) to $360 | WAT Stock New - GuruFocus
UBS Adjusts Price Target for Waters (WAT) Following Strong Quarter | WAT Stock News - GuruFocus
Analyst Boosts Price Target for Waters (WAT) Following Strong Q1 Results | WAT Stock News - GuruFocus
Waters Corporation (NYSE:WAT) Q1 2025 Earnings Call Transcript - Insider Monkey
Barclays Adjusts Price Target for Waters (WAT) Following Q1 Resu - GuruFocus
Datadog, Masimo, Waters - TradingView
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instrument Sales and Raised Guidance ... - Yahoo Finance
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instr - GuruFocus
Waters Corporation Reports Strong Q1 2025 Results - TipRanks
Decoding Waters Corp (WAT): A Strategic SWOT Insight - GuruFocus
Waters: Q1 Earnings Snapshot - CTPost
Waters Corp Earnings Call: Strong Growth Amid Challenges - TipRanks
Waters Corporation: Still A Hold After Q1 Earnings (NYSE:WAT) - Seeking Alpha
Chevron navigates rough first quarter waters - Odessa American
Waters Earnings: Fair Value Estimate Up Amid Strong Start to 2025, Including Higher Instrument Sales - Morningstar
Waters Is Recovering Following a Post-Pandemic Reset Period - Morningstar
Waters (WAT) Exceeds Q1 Revenue Forecasts with Strong Performanc - GuruFocus
Waters Corp. (WAT) Anticipates Strong Sales Growth in Q2 2025 | - GuruFocus
Waters Corp Lifts Profit Forecast After Strong Demand In Asia And Americas - Finimize
Waters Corp (WAT) Q1 2025 Earnings: Revenue Surpasses Estimates at $662M, GAAP EPS Slightly Misses at $2.03 - GuruFocus
Waters Integrates Multi-Angle Light Scattering Detectors with Em - GuruFocus
Finanzdaten der Waters Corp-Aktie (WAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.30%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):